Cyrus Biotechnology Inc. news
OpenFold, a non-profit artificial intelligence (AI) research consortium whose goal is to develop free and open source software tools for biology and drug discovery, today announced the addition of four new industry members: Bayer, Dassault Systèm
Recent advances in the architecture and scale of AI are leading us from the era of narrowly focused AI (e.g. text auto-complete, immune epitope prediction in a protein sequence, antibody domain detection) to broader models with applications across domains from sales and marketing to medical diagnostics. In protein biochemistry these are the “AIFold” models such as AlphaFold2, RoseTTAFold, and OpenFold, which outperform previous models and physics-based systems at structure predict
- Date: Thursday, February 3, 2022
- Time: 2pm ET / 11am PT
- Duration: 1 Hour
Sign up here to go to the webinar
Improving the discovery of novel drugs with artificial intelligenceLast year, Toronto-based Deep Genomics used artificial intelligence t
